Abstract
Rhamnus nakaharai Hayata (Rhamnaceae), has been used as a folk medicine in Taiwan for treating constipation, inflammation, tumors and asthma. 3-O-Methylquercetin (3-MQ), a main constituent of the plant, has been reported to inhibit total cAMP- and cGMP-phosphodiesterase (PDE) of guinea pig trachealis. Therefore we were interested in investigating the inhibitory effect of 3-MQ on various PDE isozymes from guinea pig lungs and hearts. Isolated guinea pig lungs and hearts were homogenized and centrifuged. The supernatant was chromatographed over a column of Q-sepharose, and eluted with various concentrations of NaCl. In the following order, PDE subtypes 1, 5, 2, 4 from lungs, and 3 from hearts were separated. The IC50 values of 3-MQ on these isozymes were 31.9, 86.9, 18.6, 28.5 and 1.6 μM, respectively. 3-MQ (10 - 100 μM) non-competitively inhibited PDE2, but competitively inhibited PDE4. 3-MQ (1 - 10 μM) also competitively inhibited PDE3. However, 3-MQ (10 - 100 μM) did not competitively inhibit PDE1 and 5, although it had a tendency to competitively inhibit PDE1 at concentrations of 10 - 30 μM. The present results showed that Ki value of 3-MQ was similar to that of milrinone in PDE3, and was not significantly different from that of Ro 20 - 1724 in PDE4, respectively. In conclusion, 3-MQ was revealed to be a selective and competitive PDE3/PDE4 inhibitor, although its inhibitory effect on PDE4 was not potent. Therefore, 3-MQ may have a potential in the treatment of asthma beside its antiviral activity.
Abbreviations
3-MQ:3-O-methylquercetin
PDE:phosphodiesterase
cAMP:adenosine 3′,5′ cyclic monophosphate
cGMP:guanosine 3′,5′ cyclic monophosphate
EGTA:ethylene glycol-bis(β-aminoethyl ether), N,N,N′,N′-tetraacetic acid
EDTA:ethylenediaminetetraacetic acid
BSA:bovine serum albumin
PMSF:phenylmethanesulfonyl fluoride
EHNA:erythro-9-(2-hydroxy-3-nonyl)-adenine HCl
Ro 20-1724:4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Key words
3-O-Methylquercetin -
Rhamnus nakaharai
- Rhamnaceae - guinea pig - phosphodiesterase - isozymes
References
-
1
Giembycz M A.
Phosphodiesterase 4 inhibitors and the treatment of asthma.
Drugs.
2000;
59
193-212
-
2
Torphy T J, Cieslinski L B.
Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Molecular Pharmacology.
1990;
37
206-14
-
3
Kapui Z, Schaeffer P, Mikus E G, Boronkay E, Gyürky J, Herbert J M, Pascal M.
Experimental studies on guanosine 3′,5′-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265 579 in guinea-pigs.
Arzneimittel-Forschung.
1999;
49
685-93
-
4
De Boer J, Philpott A J, van Amsterdam R G, Shahid M, Zaagsma J, Nicholson C D.
Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors.
British Journal of Pharmacology.
1992;
106
1028-34
-
5
Silver P J, Hamel L T, Perrone M H, Bentley R G, Bushover C R, Evans D B.
Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.
European Journal of Pharmacology.
1988;
150
85-94
-
6
Underwood D C, Kotzer C J, Bochnowicz S, Osborn R R, Luttmann M A, Hay D WP, Torphy T J.
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
Journal of Pharmacology and Experimental Therapeutics.
1994;
270
250-9
-
7 Chiu N Y, Chang K H. The illustrated medicinal plants of Taiwan. 5 Taipei: SMC. 1998.: P. 135-6
-
8
Ko W C, Wang H L, Lei C B, Shih C H, Chung M I, Lin C N.
Mechanisms of relaxant action of 3-O-methylquercetin in isolated guinea pig trachea.
Planta Medica.
2002;
68
30-5
-
9
Lin C N, Lu C M, Lin H C, Ko F N, Teng C M.
Novel antiplatelet naphthalene from Rhamnus nakaharai
.
Journal of Natural Products.
1995;
58
1934-40
-
10
Thompson W J, Appleman M M.
Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
Biochemistry.
1971;
10
311-6
-
11
Ahn H S, Crim W, Romano M, Sybertz E, Pitts B.
Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
Biochemical Pharmacology.
1989;
38
3331-9
-
12
Mery P F, Pavoine C, Pecker F, Fischmeister R.
erythro-9-(2-Hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
Molecular Pharmacology.
1995;
48
121-30
-
13
Harrison S A, Reifsnyder D H, Gallis B, Cadd G G, Beavo J A.
Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
Molecular Pharmacology.
1986;
29
506-14
-
14
Sheppard H, Wiggan G, Tsien W H.
Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.
Advances in Cyclic Nucleotide Research.
1972;
1
103-12
-
15
Gillespie P G, Beavo J A.
Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
Molecular Pharmacology.
1989;
36
773-81
-
16
Bradford M M.
A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Analytical Chemistry.
1976;
72
248-54
-
17
Wei B L, Lu C M, Tsao L T, Wang J P, Lin C N.
In vitro anti-inflammatory effects of quercetin 3-O-methyl ether and other constituents from Rhamnus species.
Planta Medica.
2001;
67
745-7
-
18
Cimanga K, Ying L, De Bruyne T, Apers S, Cos P, Hermans N, Bakana P, Tona L, Kambu K, Kalenda D T, Pieters L, Vanden Berghe D, Vlietinck A J.
Radical scavenging and xanthine oxidase inhibitory activity of phenolic compounds from Bridelia ferruginea stem bark.
Journal of Pharmacy and Pharmacology.
2001;
53
757-61
-
19
Laekeman G M, Claeys M, Rwangabo P C, Herman A G, Vlietinck A J.
Cardiovascular effects of 3-methylquercetin.
Planta Medica.
1986;
6
433-7
-
20
Vrijsen R, Everaert L, Van Hoof L M, Vlietinck A J, Vanden Berghe D A, Boeye A.
The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis.
Antiviral Research.
1987;
7
35-42
Prof. Dr. Wun-Chang Ko
Graduate Institute of Pharmacology
School of Medicine
Taipei Medical University
250 Wu-Hsing St.
Taipei 110
Taiwan, R.O.C.
Email: wc_ko@tmu.edu.tw
Fax: +886-2-2377-7639
